| Bioactivity | hMAO-B-IN-7 (compound 11n) is a potent and blood–brain barrier (BBB) penetrable inhibitor of human monoamine oxidase-B (hMAO-B), with the IC50 value of 0.79±0.05 μM. hMAO-B-IN-7 can be used for Alzheimer’s disease (AD) and Parkinson’s disease (PD) research[1]. |
| Name | hMAO-B-IN-7 |
| CAS | 2955577-14-5 |
| Formula | C23H19FN2O5 |
| Molar Mass | 422.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xi Zhu, et al. Exploration of the novel phthalimide-hydroxypyridinone derivatives as multifunctional drug candidates against Alzheimer’s disease. Bioorg Chem. 2023 Dec:141:106817. |
hMAO-B-IN-7
CAS: 2955577-14-5 F: C23H19FN2O5 W: 422.41
hMAO-B-IN-7 (compound 11n) is a potent and blood–brain barrier (BBB) penetrable inhibitor of human monoamine oxidase-B
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.